PLAU and neoplasm: This study provides the first characterization of the clinical toxicities, anti-tumor effects, and host-virus immunological responses of systemically administered oncolytic rLAS-uPA Newcastle disease virus administered to immunocompetent dogs with naturally occurring brain tumors.